Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Philip Spinella
With
University of Utah
University of Minnesota
Washington University School of Medicine
United States Department of Defense
University of Pittsburgh
Age
0–84
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Viable neonates ≥ 3 kg at time of enrollment (as defined in Section 4.1) OR age greater than 28 days and less than 85 years of age at time of consent; AND
Planned complex cardiac surgery with planned use of cardiopulmonary bypass, with an expectation of bleeding requiring platelet transfusion.
You may not be if
Expected order for washed or volume reduced platelets
Patient with known anti-platelet antibodies
Platelet transfusion refractoriness due to anti-HLA antibodies
Known or suspected pregnancy
Previously randomized in this study
Conscious objection or unwillingness to receive blood products
Patients intended to receive whole blood either intra-operative or post-operative for bleeding
Platelet transfusion (of any type) within 24 hours prior to the date of surgery
Pre-operative thrombocytopenia, defined as platelet count \<75x10(9)/L, based on the most recent labs completed within 72 hours prior to the date of surgery.
